RUTHE NORBRUN: Open Payments
NPI 1417258054 · JAMAICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,829 in 62 payments from 14 companies in 2025. Trend: 2023 $505 · 2024 $852 · 2025 $1,829
Food & beverage: $1,725Education: $104
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $399 |
| Neurocrine BioSciences, Inc. | 5 | $254 |
| Teva Pharmaceuticals USA, Inc. | 9 | $229 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $213 |
| Otsuka America Pharmaceutical, Inc. | 5 | $180 |
| Lundbeck LLC | 10 | $154 |
| Alkermes, Inc. | 4 | $109 |
| Janssen Pharmaceuticals, Inc | 3 | $95 |
| Vanda Pharmaceuticals Inc. | 2 | $64 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
Products named: COBENFY, INGREZZA, CAPLYTA, ABILIFY MAINTENA, ARISTADA, REXULTI, ABILIFY ASIMTUFII, UZEDY.
Industry payments across NY — which companies pay providers there.
